Subsequent research found that cardiac function in AhR−/− mice could be completely reversed with BQ-123, an ETA receptor antagonist, indicating that ET-1 could be mediated by AhR and function as the key molecule in the progression of cardiac hypertrophy [46]. The gene discussed is AHR; the disease is cardiac hypertrophy.